For patients #8, #162, #200, #229, and #260, a phosphatidylInositol‐4,5‐bisphosphate 3‐kinase catalytic subunit alpha (PIK3CA) mutation was also found at relatively comparable concentrations, suggesting the presence of a tumor clone expressing both types of mutation. Here, PIK3CA is linked to neoplasm.